alexa Basic Considerations for Container Closure Selection of
ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Basic Considerations for Container Closure Selection of Parenteral Drug Products

Lakshmi Prasanna Kolluru*

Medefil Inc, Glendale Heights, IL 60139, USA.

*Corresponding Author:
Lakshmi Prasanna Kolluru
Sr. Formulation Scientist, Medefil Inc
250/405 Windy Point Drive, Glendale Heights, IL 60139, USA
Tel: +1-630-682-4600
Email: [email protected]

Received Date: May 02, 2017; Accepted Date: May 10, 2017; Published Date: May 16, 2017

Citation: Kolluru LP (2017) Basic Considerations for Container Closure Selection of Parenteral Drug Products. Pharm Anal Acta 8:e189. doi: 10.4172/2153-2435.1000e189

Copyright: © 2017 Kolluru LP. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

By definition, container closure system encompasses all components of the packaging system that hold and protect the drug product. It includes primary packaging system (components with which the drug product comes in direct contact) and secondary packaging system (components that offer additional protection to the system but do not come in direct contact with the drug product). This article focuses on primary packaging components as they have a significant effect on the critical quality attributes of the drug product throughout the product shelf-life. Selection of an appropriate container closure system for a parenteral drug product is of utmost importance as Food and Drug Administration (FDA) classified that the probability of interaction of the drug product with the packaging component is high and the risks associated from such interactions are highest for injections administered via parenteral route [1]. Impeachment of container closure integrity leads to compromised sterility of the drug product system, which in turn is one of the major reasons for FDA drug product recalls in 2016 [2].

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords